SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-009097
Filing Date
2024-06-12
Accepted
2024-06-12 16:45:21
Documents
14
Period of Report
2024-06-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mxct-20240611x8k.htm   iXBRL 8-K 56416
2 EX-10.1 mxct-20240611xex10d1.htm EX-10.1 217550
  Complete submission text file 0001558370-24-009097.txt   444403

Data Files

Seq Description Document Type Size
3 EX-101.SCH mxct-20240611.xsd EX-101.SCH 3129
4 EX-101.LAB mxct-20240611_lab.xml EX-101.LAB 16578
5 EX-101.PRE mxct-20240611_pre.xml EX-101.PRE 10717
17 EXTRACTED XBRL INSTANCE DOCUMENT mxct-20240611x8k_htm.xml XML 5020
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

IRS No.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40674 | Film No.: 241038970
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)